ENZ (Enzo Biochem Inc.) Price-to-Projected Revenue Ratio

Brandmark of Enzo Biochem Inc. (ENZ)

Enzo Biochem, Inc. (ENZ) relies on the sale of proprietary tests, which guarantees a stable cash flow. The forward price-to-sales ratio confirms the current market valuation, where 0.60 describes the current status of the metric. Environmental initiatives help reduce laboratory waste, while a strong R&D team and the recruitment of compliance experts ensure the development of global distribution.

ENZ (Enzo Biochem) Forward Price to Sales history from 07/04/2022 to 04/26/2025

Analytical breakdowns for Enzo Biochem, Inc.

- stock price and consensus target price:
Stock Quotes Enzo Biochem|ENZ - Forecast Levels Chart
- business market valuation indicators:
Market Value Enzo Biochem, Inc.|ENZ - Total Enterprise Value
- book value of equity indicators:
Accounting Value per Share Enzo Biochem|ENZ - Accounting Value of Company|Market Capitalization to Book Value Ratio enzo.com|ENZ - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Capital Enzo Biochem, Inc.|ENZ - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Enzo Biochem|ENZ - Company Cumulative Debt|Debts to Book Capitalization Enzo Biochem, Inc.|ENZ - Company Long-Term Liabilities|Company Short-Term Debts Enzo Biochem|Quick Ratio enzo.com
- net income and valuation multiples indicators:
ENZ - Company Net Income|Expected Profit Enzo Biochem, Inc.|ENZ - Price to Earnings Ratio|Projected Price to Earnings Enzo Biochem|ENZ - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Enzo Biochem, Inc.|ENZ - Operating income before deduction of amortization|Earnings per share for the last twelve months Enzo Biochem|ENZ - Earnings per share for the last 12 months|Quarterly EPS earnings growth enzo.com|ENZ - Net earnings per share growth this year|Expected earnings per share growth for next year Enzo Biochem, Inc.
- company sales and revenue statistics:
ENZ - Company Gross Revenue|Projected Sales Volume Enzo Biochem|ENZ - Price to Sales|Price-to-Projected Revenue Ratio Enzo Biochem, Inc.
Initial company analysis:Enzo ENZ
Product sample of Enzo Biochem

This indicator compares market capitalization with expected revenue, reflecting the valuation's sensitivity to operating cash flow dynamics and margins. By outsourcing IT infrastructure while retaining rights to chemical methodologies, Enzo Biochem, Inc. (ENZ) optimizes costs, making the projected P/S ratio on the GURU.Markets platform an accurate tool for analyzing business resilience and the growth potential of asset value.

Competitors of Enzo Biochem, Inc. (ENZ)

Agilent - Forward Price-to-Revenue Multiple|DGX (Quest Diagnostics Inc.) - Future Price to Revenue|ILMN - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Exact Sciences Inc.|RVTY (Revvity, Inc.) - Forward Price-to-Revenue Multiple|bio-rad.com - Forward Price to Sales|NNNN (Anbio) - Forward P/S Multiple|Price-to-Projected Revenue Ratio SHC|Forward P/S Multiple QDEL|Market Cap to Expected Sales Ratio OPKO Health Corp.|Price-to-Projected Revenue Ratio CareDx, Inc CDNA|maravai.com (MRVI) - Market Cap to Future Revenue Ratio|Fulgent Genetics - Forward P/S Multiple|Standard BioTools Inc (LAB) - Forward Price-to-Revenue Multiple|CTKB: Forward P/S Multiple|OraSure Corp - Forward Price to Sales|XGN (Exagen Inc) - Forward P/S Multiple|Market Cap to Future Revenue Ratio mdxhealth.com MDXH|Price-to-Projected Revenue Ratio Lucid Diagnostics (LUCD)|Forward Price-to-Revenue Multiple prenetics.com PRE|Insight Molecular Diagnostics Inc - Forward Price-to-Revenue Multiple|Forward Price to Sales TRIB|ProPhase Labs, Inc. - Forward P/S Multiple|Market Cap to Expected Sales Ratio ainos.com AIMD|Co-Diagnostics (CODX) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue HSCS|BMRA (Biomerica, Inc) - Forward P/S Multiple|Forward Price-to-Revenue Multiple Cardio Diagnostics Holdings, Inc. (CDIO)|Forward Price-to-Revenue Multiple ONCO (Onconetix, Inc.)|Market Cap to Expected Sales Ratio viraxbiolabs.com|Forward P/S Multiple BJDX (Bluejay Diagnostics, Inc.)|Aspira Women's Health, Inc. (AWH) - Market Cap to Future Revenue Ratio|AXDX - Price-to-Projected Revenue Ratio|CNTG (CENTOGENE) - Market Cap to Projected Revenue|FRES (fresh2.co) - Forward Price-to-Revenue Multiple|Future Price to Revenue GENE (Genetic Technologies Limited)|Price-to-Projected Revenue Ratio 23andMe|Forward Price-to-Revenue Multiple Psychemedics Corp. (PMD)